Efficacy and Tolerability of Milnacipran in the Treatment of Major Depression in Comparison with Other Antidepressants: A Systematic Review and Meta-Analysis

By Nakagawa Atsuo  

CNS Drugs, Vol. 22, Iss. 7, 2008-01 ,pp. : 587-602

Adis International

Access to resources Recommend Favorite

Treatment of severe recurrent major depression: comparative efficacy and tolerability of moclobemide and impiramine

By Hochstrasser B.   Ferrero F.   Gachoud J.-P.   Gasser U.E.   Mascetti R.   Meyer J.W.   Wacker H.R.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 298-298

Elsevier

Access to resources Recommend Favorite

A Benefit-Risk Assessment of Agomelatine in the Treatment of Major Depression

By Howland Robert H.  

Drug Safety, Vol. 34, Iss. 9, 2011-09 ,pp. : 709-731

Adis International

Access to resources Recommend Favorite

The Emerging Role of Melatonin Agonists in the Treatment of Major Depression: Focus on Agomelatine

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 10, Iss. 1, 2011-02 ,pp. : 119-132

Bentham Science Publishers

Access to resources Recommend Favorite

Agomelatine for the treatment of major depressive disorder

By Carney Regina M   Shelton Richard C  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 15, 2011-10 ,pp. : 2411-2419

Informa Healthcare

Access to resources Recommend Favorite